These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35224452)

  • 1. Benzodiazepine Treatment and Hospital Course of Medical Inpatients With Alcohol Withdrawal Syndrome in the Veterans Health Administration.
    Steel TL; Malte CA; Bradley KA; Hawkins EJ
    Mayo Clin Proc Innov Qual Outcomes; 2022 Apr; 6(2):126-136. PubMed ID: 35224452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Symptom-Triggered Benzodiazepine Protocol Utilizing SAS and CIWA-Ar Scoring for the Treatment of Alcohol Withdrawal Syndrome in the Critically Ill.
    Sen S; Grgurich P; Tulolo A; Smith-Freedman A; Lei Y; Gray A; Dargin J
    Ann Pharmacother; 2017 Feb; 51(2):101-110. PubMed ID: 27733668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review.
    Woods AD; Giometti R; Weeks SM
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):224-52. PubMed ID: 26447017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Adjunctive Dexmedetomidine in the Treatment of Alcohol Withdrawal Compared to Benzodiazepine Symptom-Triggered Therapy in Critically Ill Patients: The EvADE Study.
    Collier TE; Farrell LB; Killian AD; Kataria VK
    J Pharm Pract; 2022 Jun; 35(3):356-362. PubMed ID: 33297835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of a modified MINDS-based protocol for management of alcohol withdrawal syndrome on an inpatient medical service.
    Krcmarik KM; Hulley BJ; Huang J; Juang D; Cadman P; Urbiztondo C; Vo C; Vargas J; Motarjemi R; Moinizandi T; Kwan B
    Pharmacotherapy; 2023 Dec; 43(12):1297-1306. PubMed ID: 37475509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of early and focused benzodiazepine therapy on length of stay in severe alcohol withdrawal syndrome.
    Lee JA; Duby JJ; Cocanour CS
    Clin Toxicol (Phila); 2019 Jul; 57(7):624-627. PubMed ID: 30729859
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the course and treatment of Alcohol Withdrawal Syndrome with the Clinical Institute Withdrawal Assessment for Alcohol - Revised: A systematic review-based meta-analysis.
    Pribék IK; Kovács I; Kádár BK; Kovács CS; Richman MJ; Janka Z; Andó B; Lázár BA
    Drug Alcohol Depend; 2021 Mar; 220():108536. PubMed ID: 33503582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eliminating the benzos: A benzodiazepine-sparing approach to preventing and treating alcohol withdrawal syndrome.
    McCullough MA; Miller PR; Martin T; Rebo KA; Stettler GR; Martin RS; Cantley M; Shilling EH; Hoth JJ; Nunn AM
    J Trauma Acute Care Surg; 2024 Mar; 96(3):394-399. PubMed ID: 37934662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Gabapentin for Alcohol Withdrawal Syndrome in the Hospital Setting: A Randomized Open-Label Controlled Trial.
    DeFoster RE; Morgan RJ; Leung JG; Schenzel H; Vijapura P; Kashiwagi DT; Fischer KM; Philbrick KL; Kung S
    Subst Use Misuse; 2023; 58(13):1643-1650. PubMed ID: 37469099
    [No Abstract]   [Full Text] [Related]  

  • 10. Symptom-triggered therapy for alcohol withdrawal syndrome in medical inpatients.
    Jaeger TM; Lohr RH; Pankratz VS
    Mayo Clin Proc; 2001 Jul; 76(7):695-701. PubMed ID: 11444401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines.
    Crispo AL; Daley MJ; Pepin JL; Harford PH; Brown CV
    Pharmacotherapy; 2014 Sep; 34(9):910-7. PubMed ID: 24898418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of an ICU-Specific Alcohol Withdrawal Syndrome Management Protocol Reduces the Need for Mechanical Ventilation.
    Heavner JJ; Akgün KM; Heavner MS; Eng CC; Drew M; Jackson P; Pritchard D; Honiden S
    Pharmacotherapy; 2018 Jul; 38(7):701-713. PubMed ID: 29800507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should the CIWA-Ar be the standard monitoring strategy for alcohol withdrawal syndrome in the intensive care unit?
    Steel TL; Giovanni SP; Katsandres SC; Cohen SM; Stephenson KB; Murray B; Sobeck H; Hough CL; Bradley KA; Williams EC
    Addict Sci Clin Pract; 2021 Mar; 16(1):21. PubMed ID: 33762020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the appropriate use of a CIWA-Ar alcohol withdrawal protocol in the general hospital setting.
    Eloma AS; Tucciarone JM; Hayes EM; Bronson BD
    Am J Drug Alcohol Abuse; 2018; 44(4):418-425. PubMed ID: 28981333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of dexmedetomidine to benzodiazepines for patients with alcohol withdrawal syndrome in the intensive care unit: a randomized controlled study.
    Bielka K; Kuchyn I; Glumcher F
    Ann Intensive Care; 2015 Dec; 5(1):33. PubMed ID: 26525052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a symptom-triggered protocol approach to the management of alcohol withdrawal syndrome in older adults.
    Taheri A; Dahri K; Chan P; Shaw M; Aulakh A; Tashakkor A
    J Am Geriatr Soc; 2014 Aug; 62(8):1551-5. PubMed ID: 24962514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fixed-dose gabapentin augmentation in the treatment of alcohol withdrawal syndrome: a retrospective, open-label study.
    Andaluz A; DeMoss D; Claassen C; Blair S; Hsu J; Bakre S; Khan M; Atem F; Rush AJ
    Am J Drug Alcohol Abuse; 2020; 46(1):49-57. PubMed ID: 31490712
    [No Abstract]   [Full Text] [Related]  

  • 18. Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial.
    Lyon JE; Khan RA; Gessert CE; Larson PM; Renier CM
    J Hosp Med; 2011 Oct; 6(8):469-74. PubMed ID: 21990176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of benzodiazepine-resistant alcohol withdrawal across a healthcare system: Benzodiazepine dose-escalation with or without propofol.
    Wong A; Benedict NJ; Lohr BR; Pizon AF; Kane-Gill SL
    Drug Alcohol Depend; 2015 Sep; 154():296-9. PubMed ID: 26205315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol withdrawal syndrome in critically ill patients: protocolized versus nonprotocolized management.
    Duby JJ; Berry AJ; Ghayyem P; Wilson MD; Cocanour CS
    J Trauma Acute Care Surg; 2014 Dec; 77(6):938-43. PubMed ID: 25248063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.